6-tert-Butyldimethylsilyl-4'-hydroxy Raloxifene is a chemical compound identified as an active pharmaceutical ingredient (API) impurity. It is a derivative of raloxifene, modified with a tert-butyldimethylsilyl group and a hydroxy substituent, and is used primarily in pharmaceutical manufacturing and quality control processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 174264-47-2
4'-tert-Butyldimethylsilyl-6-hydroxy Raloxifene
pharmaceutical raw material
Raloxifene hydrochloride
pharmaceutical raw material
Raloxifene 6-glucuronide
pharmaceutical raw material
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-|A-D-glycopyranuronate)
pharmaceutical raw material
Riluzole
pharmaceutical raw material
Amiloride hydrochloride dihydrate
pharmaceutical raw material
[6-Methoxy-2-(4-methoxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone
pharmaceutical raw material
4-Hydroxy Raloxifene
pharmaceutical raw material
[6-[tert-butyl(dimethyl)silyl]oxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
LVZAJJMYYKOTDQ-UHFFFAOYSA-N
CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1)C(=C(S2)C3=CC=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5
—